The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.
- DOI
- 10.1126/scitranslmed.aal4682
- Published
- 2017 May 24
- Container
- Science translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1126/scitranslmed.aal4682,
title = {The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.},
author = {Kodack DP and Askoxylakis V and Ferraro GB and Sheng Q and Badeaux M and Goel S and Qi X and Shankaraiah R and Cao ZA and Ramjiawan RR and Bezwada D and Patel B and Song Y and Costa C and Naxerova K and Wong CSF and Kloepper J and Das R and Tam A and Tanboon J and Duda DG and Miller CR and Siegel MB and Anders CK and Sanders M and Estrada MV and Schlegel R and Arteaga CL and Brachtel E and Huang A and Fukumura D and Engelman JA and Jain RK},
year = {2017},
journal = {Science translational medicine},
doi = {10.1126/scitranslmed.aal4682},
url = {https://doi.org/10.1126/scitranslmed.aal4682}
}RIS
TY - JOUR TI - The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation. AU - Kodack DP AU - Askoxylakis V AU - Ferraro GB AU - Sheng Q AU - Badeaux M AU - Goel S AU - Qi X AU - Shankaraiah R AU - Cao ZA AU - Ramjiawan RR AU - Bezwada D AU - Patel B AU - Song Y AU - Costa C AU - Naxerova K AU - Wong CSF AU - Kloepper J AU - Das R AU - Tam A AU - Tanboon J AU - Duda DG AU - Miller CR AU - Siegel MB AU - Anders CK AU - Sanders M AU - Estrada MV AU - Schlegel R AU - Arteaga CL AU - Brachtel E AU - Huang A AU - Fukumura D AU - Engelman JA AU - Jain RK PY - 2017 JO - Science translational medicine DO - 10.1126/scitranslmed.aal4682 UR - https://doi.org/10.1126/scitranslmed.aal4682 ER -
APA
DP, K., V, A., GB, F., Q, S., M, B., S, G., X, Q., R, S., ZA, C., RR, R., D, B., B, P., Y, S., C, C., K, N., CSF, W., J, K., R, D., A, T., J, T., DG, D., CR, M., MB, S., CK, A., M, S., MV, E., R, S., CL, A., E, B., A, H., D, F., JA, E., & RK, J. (2017). The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.. Science translational medicine. https://doi.org/10.1126/scitranslmed.aal4682
Source records
- pubmed · retrieved 2026-09-26T18:44:57.811Z
- europe-pmc · retrieved 2026-09-26T18:44:57.826Z